Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

45 results about "Iontophoresis therapy" patented technology

Therapeutic introduction of ions of soluble salts into tissues by means of electric current; a form of electro-osmosis; also, a process of increasing the penetration of drugs into surface tissues by the application of electric current.

Glucose measuring assembly with a hydrogel

This invention relates to methods for reducing the presence of a compound in an ionically conductive material, e.g., for use in iontophoretic devices, wherein the presence of the compound interferes with detecting a selected analyte. Removal of the compound can typically take place either during or after the manufacture of the ionically conductive material or an assembly comprising this material. Also disclosed are methods for generating selectively permeable barriers on the reactive faces of electrodes. Further, this invention relates to hydrogels comprising one or more biocides, as well as assemblies containing such hydrogels.
Owner:LIFESCAN IP HLDG LLC +1

Method for increasing the battery life of an alternating current iontophoresis device using a barrier-modifying agent

An iontophoretic method for transporting compounds of interest across a body tissue is provided. The method utilizes an AC signal in conjunction with a barrier-modifying agent such as a fatty acid, fatty alcohol, bile acid, surfactant, or the like. The method enables the maintenance of a substantially constant electrical state in a localized region of the tissue through which transport occurs, thereby allowing a compound of interest to be transported across the tissue in a controlled and predictable manner. The barrier-modifying agent reduces the time as well as the voltage level required to achieve a target electrical resistance, thereby reducing patient discomfort and increasing the battery life of the iontophoresis device.
Owner:ACIONT

Iontophoretic electrode with improved current distribution

An electrode for use in an iontophoretic drug delivery having a substantially uniform distribution of current about the electrode. One such electrode includes a substrate, at least one first conductive layer of material disposed upon the substrate and at least one dielectric layer of material disposed upon at least a portion of the at least one conductive layer of material. The dielectric layer cooperates with the conductive layer of material to promote the substantially uniform distribution of current. Another such electrode includes a substrate, a conductive layer of material and a sacrificial layer of material.
Owner:ENCORE MEDICAL ASSET CORP

Method and device for the iontophoretic delivery of a drug

An iontophoretic drug delivery device storage apparatus and a method of using that device is disclosed. The device comprises a fluid reservoir, an electrode assembly and a tray apparatus. The fluid reservoir is capable of retaining a medicament and has a sealed fluid chamber defined by at least one seal. The seal includes a weaker region and a pinch-like configuration associated with that region such that application of pressure to the fluid reservoir breaks the weaker region of the seal, releasing the retained medicament. The electrode assembly comprises an active electrode, at least two passive electrodes a medicament carrying region, and a moat region around the medicament carrying region so that once fluid is delivered from the fluid reservoir to the electrode assembly the fluid is substantially retained in the medicament carrying means.
Owner:ENCORE MEDICAL ASSET CORP

Antiperspirant and deodorant products and methods for their use

A new method for the inhibition of human sweating and body malodour is described. An agent capable of blocking calcium channels in the secretory coil cells of human sweat glands is topically applied; on reaching the secretory coil cells, the action of this agent results in reduced sweat production. Preferred agents are natural plant extracts. The transport of the agent to the secretory coil is preferably enhanced in some way, for example by iontophoresis or the use of a skin penetration enhancer. Antiperspirant products comprising a calcium channel blocking agent and a pore-blocking antiperspirant active are also claimed.
Owner:UNILEVER HOME & PERSONAL CARE USA DIV OF CONOPCO IN C

Targeted And Individualized Delivery Of Skincare Treatments With Micro-Current In A Mask Or Patch Form

Cosmetic facial treatment delivery system with skincare benefit agents and iontophoresis micro-current zones are provided for delivering skincare treatments to multiple targeted areas of the skin to treat different concerns of an individual user. The system includes a sheet substrate with skincare agents and a micro-current generator secured to the sheet. The micro-current generator includes an oxidation agent, a reduction agent and a hydrogel with salt. The generator is activated by wetting to produce micro-current. The sheet is applied to skin. The micro-current generated facilitates delivery of skin benefit agents from the sheet by iontophoresis, or directly affects treatment by delivery of iontophoresis micro-current to the skin.
Owner:ELC MANAGEMENT LLC

Iontophoretic device with improved counterelectrode

InactiveUS20100286590A1Enhanced electrode constructionElectrotherapyMedical devicesIontophoresis therapyDrug reservoir
The present disclosure relates to an iontophoretic device. In one aspect, the device includes a barrier layer between the drug reservoir and wearer. In another aspect, the device includes a counterelectrode opposite the driving electrode relative to the drug reservoir.
Owner:ISIS BIOPOLYMER

Pharmaceutical composition comprising rotigotine salts (acid or na), especially for iontophoresis

InactiveUS20120101146A1Enhanced iontophoretic deliveryGood to excellent solubilityBiocideElectrotherapyRotigotineDrug
The present invention relates to new salts of 6-(propyl-(2-thiophen-2-ylethyl)amino)tetralin-1-ol (rotigotine), their use as a medicament, for example for the treatment of CNS disorders like Parkinson Disease, RLS, fybromyalgia and / or depression, in particular through electromotive administration. The present invention relates to pharmaceutical formulations suitable for iontophoresis that provide enhanced iontophoretic delivery of rotigotine to at least one target tissue. The formulations are further characterized by good to excellent solubility of the salts in aqueous solutions.
Owner:UCB SA

Iontophoresis apparatus

An iontophoresis device comprising (A) a working electrode assembly having a working electrode, a medicine-containing portion and an ion-exchange membrane, (B) a counter electrode assembly having an electrode which opposes the working electrode, and (C) a power source unit electrically connected to the working electrode assembly and to the counter electrode assembly, enabling an ionic medicine contained in the medicine containing portion to be permeated into a living body by the electrophoresis through the ion-exchange membrane, wherein the ion-exchange membrane has a structure in which voids of a porous film are filled with an ion-exchange resin. The iontophoresis device using the above ion-exchange membrane makes it possible to administer the medicine in amounts larger than those accomplished by using the conventional devices.
Owner:TOKUYAMA CORP

Method for electrokinetic delivery of medicaments

InactiveUSRE38341E1Good curative effectImproved disposable iontophoretic medicament applicatorElectrotherapyMedical devicesIontophoresis therapyCutaneous membrane
A portable iontophoresis apparatus for facilitating delivery of medication across the cutaneous membrane into adjacent underlying tissues and blood vessels. The apparatus employs a modular, detachable non-reusable medicament-containing applicator electrode which is adapted to attach to a base assembly. The apparatus is designed to be hand-held and includes a circumferential tactile electrode band on the base assembly which provides electrical connection between the skin of the user's hand and one pole of a bipolar power source housed within the base assembly. The opposing pole of the power source is connected to the applicator electrode. The user's body completes the electrical circuit between the applicator and tactile electrodes. A method for using the device for the treatment of Herpes simplex infection and related viral infections which produce similar cutaneous lesions is presented. The apparatus, when used in accordance with the method described herein, demonstrated >90% treatment efficacy in clinical trials.
Owner:NITRIC BIOTHERAPEUTICS INC

Method and device for the iontophoretic delivery of a drug

An iontophoretic drug delivery device storage apparatus and a method of using that device is disclosed. The device comprises a fluid reservoir, an electrode assembly and a tray apparatus. The fluid reservoir is capable of retaining a medicament and has a sealed fluid chamber defined by at least one seal. The seal includes a weaker region and a pinch-like configuration associated with that region such that application of pressure to the fluid reservoir breaks the weaker region of the seal, releasing the retained medicament. The electrode assembly comprises an active electrode, at least two passive electrodes a medicament carrying region, and a moat region around the medicament carrying region so that once fluid is delivered from the fluid reservoir to the electrode assembly the fluid is substantially retained in the medicament carrying means.
Owner:ENCORE MEDICAL ASSET CORP

System and method for controlling the iontophoretic delivery of therapeutic agents based on user inhalation

Embodiments of the invention provide methods for the transdermal delivery of therapeutic agents for the treatment of addictive cravings e.g., from nicotine. An embodiment of a method for such delivery comprises positioning at least one electrode assembly in electrical communication with a patient's skin. The assembly includes a solution comprising a therapeutic agent which passively diffuses into skin. A dose of agent is delivered from the assembly into skin during a first period using a first current having a characteristic e.g., polarity and magnitude, to repel agent out of the assembly. During a second period, a second current having a characteristic to attract agent is used to retain agent in the assembly such that delivery of agent into skin is minimized. In particular embodiments, a dose of agent may be delivered on-demand using an input from the patient using an inhalation sensing device which mimics an inhaled form of tobacco.
Owner:INCUBE LABS

Laminitis treatment system and method

A system and methodology for treatment of circulation related conditions in hooved animals such as laminitis in horses. The methodology employs a garment wrap that is releasably secured to the animal's leg. The wrap includes several inflatable chambers, one of which, the most distal one, engages the frog and bulbar sections of the horses hoof. The methodology calls for the pressuring of the inflatable chambers in accordance with a sequence that prevents backflow from a more proximal point on the animal's leg to a more distal point on the leg. A boot arrangement including an inner sole pad are also utilized both during the therapy procedure and afterwards. The inner sole pad can provide related medications and can be used in an iontophoresis procedure.
Owner:MEDERGO ASSOC

Iontophoretic delivery of rotigotine for the treatment of Parkinson's disease

InactiveUS7632859B2Reduce solubilityRapid start and terminationBiocideElectrotherapyRotigotineDisease
By using a composition comprising rotigotine and at least one chloride salt in a concentration of 1 to 140 mmol / l, the composition having a pH of 4 to 6.5 in a iontophoretic device for the treatment of Parkinson's disease, it became possible to obtain a rotigotine flux across the human stratum corneum which was higher than the one previously obtained with conventional passive diffusion systems.
Owner:UCB SA

Process for preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties

A method for preparing hydrophilic pressure sensitive adhesive (PSA) compositions is provided, wherein the method enables preparation of adhesives having a particular, optimized degree of adhesion. That is, the hydrophilic PSA is comprised of a hydrophilic polymer and a complementary short-chain plasticizing agent, wherein the hydrophilic polymer and plasticizing agent are capable of hydrogen bonding or electrostatic bonding to each other and are present in a ratio that optimizes key characteristics of the adhesive composition, such as adhesive strength, cohesive strength and hydrophilicity. The adhesive is useful in a wide variety of contexts, e.g., as a biomedical adhesive for application to the skin or other body surface, and as such finds utility in the areas of drug delivery systems (e.g., topical, transdermal, transmucosal, iontophoretic), medical skin coverings and wound healing products and biomedical electrodes.
Owner:A V TOPCHIEV INST OF PETROCHEM +5

Iontophoresis Device

An comprising (A) a working electrode structure being equipped with a working electrode, an ion-exchange membrane and a medicine-containing portion which contains an ionic medicine, (B) a counter electrode structure being equipped with an electrode opposing said working electrode and (C) a power source unit electrically connected to the working electrode structure and to the counter electrode structure, said ionic medicine being permeated into a living body by the electrophoresis through the ion-exchange membrane; wherein said ion-exchange membrane has, as an ion-exchange resin, a crosslinked (meth)acrylic resin having a (meth)acrylic structural unit A to which an ion-exchange group is bonded. The iontophoresis device using the above ion-exchange membrane is capable of efficiently administering ionic medicines having ionic formula weights of not smaller than 500 into the living body.
Owner:TOKUYAMA CORP

Drug product, a method of administrating a vaccine using the drug product, and an apparatus for iontophoresis

It is an object of the present invention to provide a method and an apparatus capable of noninvasively administrating vaccine through the skin, and thereby making the immune response activate. A drug product according to the present invention is characterized in that the drug product has a support medium, an electrode formed on the support medium and protected partly by an insulating material for avoiding a direct cutaneous contact, a vaccine containing layer for containing a vaccine, wherein the vaccine is an antigen for inducing an immune suppression protein. A method of administrating a vaccine according to the present invention is characterized in that the vaccine is administrated by the iontophoresis using the drug product according to the drug product of the present invention as an electrode. An apparatus for the iontophoresis according to the present invention is characterized in that the drug product according to the present invention is used as an electrode.
Owner:JOSAI UNIV CORP

Dosage control electrode for iontophoresis device

ActiveUS7031769B2Maintenance of effectAccurate and positive shutoff and circuit breaking deviceInternal electrodesMedical devicesConductive materialsMedicine
An electrode assembly for use in an iontophoresis device for the transcutaneous administration of an active therapeutic species includes a base layer of conductive material which is consumed (oxidizes or reduces) preferentially to water, a first upper layer of sacrificial material coated on a first portion of the base layer wherein the sacrificial material is consumed preferentially to the conductive material of the base layer. A second upper layer of non-conducting material is coated on a second portion of the base layer, the second upper layer being spaced from the first upper layer, a narrow exposed linking area of the base layer material remaining therebetween. The exposed linking area of the base layer extends across the base layer. During operation of an associated iontophoresis device, the sacrificial material will be sequentially consumed; the first upper layer will be followed by the exposed linking area of the base layer which severs the base layer thereby breaking circuit continuity in the device.
Owner:THE TAPEMARK

Iontophoretic delivery system

Methods, systems and other embodiments associated with administering ionotophoretic medicines are presented. A method of administering ionotophoretic medicines includes applying a voltage across a body tissue and an iontophoretic solution including medicine. At least some of the iontophoretic solution including medicine is then injected into the body tissue without requiring the iontophoretic transportation of the iontophoretic solution including medicine through the skin. The iontophoretic solution is typically injected while the voltage is applied. The voltage causes an ionic current of iontophoretic medicine to flow which disperses the medicine within the body tissue toward body tissue connected to the voltage.
Owner:KOPMAN STANLEY E

Smart contact lens for non-invasive drug delivery

Provided is a smart contact lens for non-invasive drug delivery including a platform configured to be worn on an eye, a reservoir installed within the platform, and having a receiving part in which a drug is received, to provide the eye with the drug, an electrode for iontophoresis installed in the reservoir to make iontophoresis work, to provide the eye with the drug from the reservoir, and an activation chip electrically connected to the electrode for iontophoresis to activate iontophoresis.
Owner:KOREA INST OF SCI & TECH

System for the transdermal delivery of active ingredient

The invention relates to a transdermal therapeutic system (TTS) for delivering pharmaceutical active ingredients. The TTS includes a cover layer and at least one active-ingredient-containing carrier material. At least one retaining element is located between the active-ingredient-containing carrier material and the cover layer, with the retaining element fixing the active-ingredient-containing carrier material onto the cover layer. The invention further relates to a method for fastening an active-ingredient-containing carrier material to a cover layer of a TTS in the presence of hook-and-loop strip segments and the use of a hook-and-loop strip in transdermal or iontophoretic administration of pharmaceutical or therapeutic active ingredients to patients.
Owner:LTS LOHMANN THERAPIE-SYST AG

Iontophoresis device adopting efficient environment-friendly biocompatible ion battery

The invention relates to an iontophoresis device adopting an efficient environment-friendly biocompatible ion battery, in particular to an efficient environment-friendly biocompatible iontophoresis device driven by a reverse electrodialysis ion battery, which is made of substances, such as sediments, gas or non-ionidizable substances in water solution, formed through a reaction..
Owner:成都怀慈福佑电子科技有限公司

Wearable devices

This disclosure provides self-applied wearable devices configured to electrically stimulate a user, generate and / or collect a user's electrophysiological data via electrodes, in contact with the outer layer of skin, that hydrate the skin surface using iontophoresis, reverse iontophoresis, and / or a combination thereof. The wearable devices provided herein increase conductivity and / or move biological ions and / or polar molecules from the electrode into the outer skin layer of skin surface to reduced impedance between the outer skin layer and electrode, wherein the impedance between electrodes is matched and / or minimized. This disclosure also provides systems comprising the same, and methods for making and using the same.
Owner:CARL TURNER

Transdermal drug delivery system

An embodiment relates to a transdermal drug delivery system comprising a patch comprising a) a cartridge comprising a drug; b) a bio-sensor and a non bio-sensor; c) an active delivery pad comprising an electrode for delivery of the drug into a tissue via iontophoresis; d) a power source of electrical energy connected to the electrode; e) a microcontroller configured to control a release of the drug wherein the patch is attached to the tissue via an adhesive pad, and optionally top of patch is covered with a sheet; wherein the bio-sensor is configured to detect a physiological parameter; wherein the non bio-sensor is configured with a software to control working of the patch.
Owner:JAIN ISHAAN +3

A system of method for treatment of hyperhidrosis by tap-water iontophoresis and electrotherapy using an improved electrode

In one embodiment of the present invention, a method and system for the safe use of a tap-water iontophoresis machine is provided. The method is based on the specific treated zone by establishing several different treatment safety parameters according to which treated body zone is selected, such as the hands, feet, or armpits. The system includes a microcontroller, a voltage measuring module, current measuring module, polarity inversion module, and an optional resistance measuring module. The microcontroller adjusts the treatment based on the following: (a) the profile selected; (b) the values embedded in the microcontroller that is associated to the profile selected; and, (c) the values measured by the different modules and the time kept by the microcontroller. By simply choosing the treated zone, the device automatically adjusts these parameters to better reflect the specific particularities of that zone and establish often narrower ranges of values and increase safety and comfort for the patient.
Owner:马克西姆卡鲁什 +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products